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increasing burden on general practice
Cecile JL Koelink*, Boudewijn J Kollen, Feikje Groenhof, Klaas van der Meer and Wouter K van der HeideAbstract
Background: Skin cancer is believed to impose a heavy burden on healthcare services, but the burden of skin
lesions suspected of malignancy on primary healthcare has never been evaluated. Therefore the aim of this study
was to determine the demand for care in general practice due to these suspected skin lesions (i.e. lesions that are
suspected of malignancy by either the patient or the GP).
Methods: Registry study based on data (2001–2010) from the Registration Network Groningen. This is a general
practice registration network in the northern part of the Netherlands with an average annual population of
approximately 30,000 patients. All patient contacts are coded according to the International Classification of Primary
Care (ICPC). Consultations for skin lesions suspected of malignancy were selected according to the assigned ICPC
codes. Subsequently, the number of consultations per year and the annual percent change in number of contacts
(using the JoinPoint regression program) were calculated and analysed. Additionally, the percentage of patients
referred to secondary care or receiving minor surgery within one year after the first contact were calculated.
Results: From 2001 onwards we found an annual increase in demand for care due to skin lesions suspected of
malignancy of 7.3% (p < 0.01) and in 2010 the benign:malignant ratio was 10:1. In total 13.0% of the patients were
referred and after 2006, minor surgery was performed on 31.2% of the patients. Most surgeries and referrals took
place within 30 days.
Conclusions: Suspected skin lesions impose an increasing burden on primary healthcare and most likely on
healthcare costs as well. General practitioners should therefore be trained in diagnosing skin lesions suspected of
malignancy, as a high diagnostic accuracy can save lives in the case of melanoma, and may also prevent
unnecessary, costly, excisions and referrals to secondary healthcare.
Keywords: Skin Neoplasms, Family practice, Physicians, Family, Netherlands, Referral and consultation, Surgical
procedures, MinorBackground
Skin cancer incidence is rising [1-6]. In the Netherlands,
one in six people are expected to develop skin cancer
[7]. Public awareness is also rising as a result of many
public information campaigns [8-11] and this may lead
to an increased consultation rate. These consultations
also include non-malignant skin lesions. In fact, the ma-
jority of patients visiting their physician for a skin lesion
suspected of malignancy do not have skin cancer. De
Vries et al.has suggested that for every new case of skin
cancer another 20–50 patients will consult their general* Correspondence: c.j.l.koelink@umcg.nl
Department of General Practice, University of Groningen, University Medical
Center Groningen, PO Box 196, Huispostcode FA 20, 9700 AD Groningen,
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reproduction in any medium, provided the orpractitioner (GP) or dermatologist [12]. This estimate
lacks solid evidence, but seems to be in line with daily
practice.
In the Netherlands, the GP has a gatekeeper role and
patients visit their GP first for any health-related ques-
tion. The GP can perform a diagnostic procedure, which
may include an excision or referral to the dermatologist
in the case of suspected lesions. Despite the large num-
ber of encounters for skin lesions, many GPs lack a solid
training in dermatology [13,14]. In contrast to the UK
[14], no specific guideline for skin lesions suspected of
malignancy is available in the Netherlands.
We believe that knowledge on healthcare demands for
skin lesions suspected of malignancy (i.e. lesions that areLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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is important. It may identify areas for training as well as
revealing possibilities for substitution of care.
Therefore, the aim of this study was to determine the
demand for care in general practice due to skin lesions
suspected of malignancy for the period 2001–2010. We
were particularly interested in the consultation rates
and subsequent treatments by GPs, including watchful
waiting, excision of the lesion and referral to secondary
care.
Methods
We performed a retrospective analysis on data from the
Registration Network Groningen (RNG). This network
was established in 1989 and consists of patient registra-
tions of three general practices with 17 GPs in the
north-eastern part of the Netherlands. The RNG in-
cludes a dynamic population with an average annual
population of approximately 30,000 patients. For all pa-
tients, both symptoms and diagnoses are coded (by the
GPs), according to the International Classification of Pri-
mary Care (ICPC) [15,16]. Treatments such as minor
surgery and referrals are registered as well. All GPs in
this network are especially trained for this type of ICPC
registration.
All patients aged 18 years and older were selected,
with a consultation for skin lesions suspected of malig-
nancy between 2001 and 2010. To identify consultations
for skin lesion suspected of malignancy without running
the risk of also selecting too many consultations for
other reasons, 2 GPs (KvdM and WvdH; both > 25 years
of experience) and 1 researcher (CK) selected the ICPC
codes. Consequently, the following ICPC codes S26 (Fear
of cancer of skin), S77 (Malignant neoplasm of skin), S79
(Benign neoplasm of skin, other), S80 (Unspecified neo-
plasm of skin, other), S81 (Haemangioma/lymphangioma),
S82 (Naevus/mole), S83 (Congenital skin anomaly, other)
and S99 (Skin disease, other) were used for this analysis.
The latter ICPC code was included because it also in-
cludes verruca seborrhoica, kerato-acanthoma and actinic
keratosis (see Additional file 1).
We calculated the annual number of contacts, referrals
and minor surgery for lesions suspected of malignancy
per 1,000 patients. For this, we first calculated the total
number of patients per year in the database. As the
RNG consists of a dynamic population, this was done by
counting the true number of person-years for each year
based on the actual days during the year in which the
patient was present in the database (i.e. registered at one
of the practices).
Subsequently, we also assessed which percentage of
the patients received an intervention, i.e. either minor
surgery performed by their GP or referral to secondary
care, within 1 year after their first consultation for oneof the above mentioned ICPC codes. Due to the small
number of annual consultations (<25), codes S26, S81
and S83 were not included in the analysis. For minor
surgery, we selected patients with a first visit from 2006
onwards. This period was chosen, because from that
year onwards a new financial contract for GPs was intro-
duced which led to improved registration of minor sur-
gery. Before 2006 no trustworthy data on minor surgery
could be retrieved. However, referrals have always been
registered and for this intervention we selected the
period from 2001 onwards. A first visit was defined as
having no earlier contact for the analysed ICPC code in
the database.Analyses
Slope differences from zero at alpha 0.05 and the annual
percent change (APC) in number of contacts, referrals
and minor surgery were estimated and analysed for
trend significance, using the JoinPoint Regression Pro-
gram, version 3.5.2. October 2011 of the Statistical Re-
search and Applications branch of the US National
Cancer Institute. This was done for all lesions as well as
separately for malignant and benign lesions.
Descriptive analyses were used to report the percent-
age of patients being subjected to an intervention, the
median time to the intervention and the percentage of
patients with an intervention 30 and 90 days after the
first consultation. For this, SPSS version 18 was used.
A difference with a p-value <0.05 was considered
significant.
As all data were received anonymously no ethical ap-
proval for this study was needed. This was confirmed by
the Medical Ethical Board of the University Medical
Center Groningen.Results
On average, there were 22,343 patients aged 18 years
and older per year in this study.Number of contacts per year
From 2001 to 2010, 16,337 contacts of 7034 different pa-
tients (median number of contacts: 2) for skin lesions
suspected of malignancy were registered. The total num-
ber of contacts per year increased by 54.8% from 60.6
contacts/1,000 patients in 2001 to 93.8 contacts/1,000
patients in 2010. This was a significant increase with an
annual percent increase of 7.3 (p < 0.01) (Table 1, Figure 1).
This increase was shown for both malignant (ICPC S77;
annual percent change 11.8) and non-malignant (other
ICPC codes; annual percent change 6.9) lesions (Figure 2).
In 2010 only 1 in 10 skin lesions suspected of malignancy
was malignant (Table 2).









S82 (Naevus/mole) S99 (Skin disease, other) S26; S81; S83 (Fear of




2001 3.3 (73) 20.9 (465) 3.6 (81) 22.9 (510) 8.7 (194) 1.1 (25) 60.6
2002 4.0 (88) 19.4 (427) 2.5 (55) 19.3 (425) 5.0 (110) 1.1 (24) 51.4
2003 4.8 (107) 19.8 (438) 1.7 (38) 22.1 (488) 9.5 (211) 1.4 (31) 59.4
2004 3.6 (81) 20.5 (461) 1.9 (42) 20.1 (452) 11.1 (249) 0.7 (15) 57.9
2005 6.7 (153) 22.7 (520) 0.9 (21) 19.9 (456) 13.4 (307) 0.7 (17) 64.4
2006 9.1 (199) 26.1 (574) 2.2 (48) 20.6 (452) 14.2 (311) 1.4 (31) 73.6
2007 10.4 (232) 24.5 (547) 4.0 (89) 28.1 (626) 16.7 (372) 1.2 (27) 85.0
2008 7.2 (161) 29.7 (667) 4.8 (109) 30.5 (685) 16.5 (372) 1.6 (36) 90.3
2009 7.6 (172) 26.2 (592) 5.4 (121) 33.0 (745) 20.8 (470) 1.2 (27) 94.3
2010 8.4 (189) 27.6 (621) 5.2 (116) 29.2 (657) 22.4 (504) 0.9 (21) 93.8
Koelink et al. BMC Family Practice 2014, 15:29 Page 3 of 6
http://www.biomedcentral.com/1471-2296/15/29Patients receiving minor surgery
A total of 4,513 patients had a first visit for a skin lesion
suspected of malignancy from 2006 onwards. In 31.2%
of these patients, GPs performed minor surgery within
one year after their first contact. The median time from
the first contact to minor surgery was 6 days. After
30 days, 91.8% of all minor surgery had taken place, after
90 days this percentage increased up to 96.9%. The total
number of patients receiving minor surgery increased
from 13.7/1,000 patients in 2006 to 18.4/1,000 patients in
2010, which represents an annual percent increase of 7.9
(p = 0.13) (Figure 3).
Patients referred to secondary care
Of the 8,228 patients with a first contact for a skin lesion
suspected of malignancy from 2001 onwards, 13.0% wereFigure 1 Total number of contacts per 1,000 patients per year. (line =referred to secondary healthcare at or within one year
after the first consultation. As more than half of the pa-
tients were referred on the day of the consultation, the
median time to referral was 0 days; 88.1% of the patients
were referred within 30 days after the first visit and after
90 days, 92% of the referrals had taken place. The total
number of referrals increased from 4.7/1,000 patients in
2001 to 8.7/1,000 patients in 2010. This corresponded to a
significant annual increase of 8.3% (p < 0.01) (Figure 4).
Discussion
Summary of main findings
This study shows that skin lesions suspected of malig-
nancy impose an increasing burden on general practice.
During the period 2001–2010, the demand on care for
skin lesions suspected of malignancy increasedtrend line, APC = annual percent change).
Figure 2 Total number of contacts for malignant (•) and benign (+) skin lesions per 1,000 patients per year. (line = trend line, APC = annual
percent change).
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of 7.3, leading to 93 contacts/1,000 patients/year in
2010. The majority of these contacts are due to benign
lesions. A large proportion, 13.0%, of the new lesions are
referred to secondary care and the GP performed minor
surgery on more than 31% of the new lesions. Almost all
referrals and minor surgery took place within 30 days
after the first visit, suggesting that GPs make prompt de-
cisions concerning the treatment.
Context with other literature
In this study we found that a Dutch GP was consulted
93.8 times per year per 1000 patients older than 18 years
in 2010. This increasing demand, if persevering, may
eventually approach the estimated increase reported byTable 2 Benign/malignant ratio of skin lesions suspected
of malignancy per year
Year Benign: Malignant
2001 17.5 : 1
2002 11.8 : 1
2003 11.3 : 1
2004 15.0 : 1
2005 8.6 : 1
2006 7.1 : 1
2007 7.2 : 1
2008 11.6 : 1
2009 11.4 : 1
2010 10.2 : 1de Vries et al. of 2 consultations/day in the year 2015
[12]. It is common knowledge that dermatology is a spe-
cialist area GPs often refer to [17]. This study shows that
skin lesions suspected of malignancy must constitute a
large group of these referrals. Within 1 year after the
first visit, 13.0% of the patients were referred to second-
ary care. An even greater proportion of the patients, i.e.
31.2%, had their skin lesion removed by the GP. These
percentages are comparable to the 10.2% and 27.4% re-
spectively observed by van Dijk et al. [18] The minor
differences observed are probably due to a different se-
lection of skin lesions as van Dijk et al. only studied
benign neoplasms of the skin and naevi, and included
episodes of care instead of first contacts.
Implications of results
As demonstrated by our study, GPs are frequently and
increasingly confronted with the care of skin lesions sus-
pected of malignancy. Most of these lesions are benign
and although the number of contacts for malignant le-
sions are increasing at a higher rate than the number of
contacts for benign lesions, in 2010, only 1 in 10 skin le-
sion suspected of malignancy was malignant. Further-
more, the total number of excisions (registered as minor
surgery) and referrals showed an annual increase of 7.9%
and 8.3% respectively, which is slightly higher than the
7.3% increase in the total number of contacts for skin le-
sions suspected of malignancy found in this study. This
increasing demand for care in general practice, but as
seen by the increase in referrals to secondary care as
well, is likely to result in an increasing burden on
Figure 3 Minor surgery (number of excisions) per 1,000 patients per year (line = trend line, APC = annual percent change).
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are adequately trained to diagnose and treat skin le-
sions that are suspected of malignancy as early detec-
tion can save lives, in the case of melanoma, while ruling
out malignancy at an early stage may prevent unnecessary,
costly, excisions and referrals to secondary care. Yet GPs in
both the UK and the Netherlands receive only limited
training in dermatology [13,14] and it has been suggestedFigure 4 Total number of referrals per 1,000 patients per year (line =that GPs’ skills of diagnosing skin lesions could be im-
proved [19]. On the other hand, one study found that mel-
anoma are not likely to be excised more inadequately in
primary care than they are in secondary care [20]. Never-
theless, ensuring that GPs and GP registrars acquire a satis-
factory level of dermatological knowledge for the accurate
diagnosis and treatment of skin cancer should have
priority.trend line, APC = annual percent change).
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As in every healthcare database, the reliability is dependent
on the accuracy of registration. Therefore all GPs partici-
pating in the RNG receive special training to maintain op-
timal registration. A limitation of this database is that it
does not distinguish between consultations that were genu-
inely used for diagnosing skin lesions that were suspected
of malignancy by either the patient or the GP and those
that were not. However, we believe that, based on the se-
lected ICPC codes, we predominantly identified suspected
lesions. Because the reported numbers merely represent an
indication of provided care rather than an absolute number
of true skin lesions suspected of malignancy they should
therefore be interpreted with caution. Also, in this database
it is not clear whether the reason for the next consultation
was prompted by exactly the same lesion or another lesion.
As this may bias the percentage of patients subjected to
minor surgery or who were referred to secondary care, we
decided to consider only the data of the first visit and the
following year for the analysis. However, we are confident
that the analysis based on this large primary care database
enabled us to draw valid conclusions on the burden that
skin lesions suspected of malignancy impose on general
practice. And although this study was conducted in the
northern part of the Netherlands, we believe that with in-
creasing incidence rates of skin cancer all over Europe
[3-5], the observed trends in this study should be similar in
other countries.
Conclusions
Skin lesions that are suspected of malignancy impose an
increasing burden on primary healthcare and most likely
on healthcare costs as well. Especially, as many of these
lesions are either excised or referred to secondary health-
care. General practitioners should therefore be trained in
diagnosing these lesions, as a high diagnostic accuracy can
save lives in the case of melanoma. Additionally, it may
also prevent unnecessary, costly, excisions and referrals to
secondary healthcare.
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